R&D

Closing the blind spots in clinical care. Real-time patient monitoring powered by AI and wearable technology.
Built for the unseen Filling the gaps beyond hospital walls with continuous,
technology-driven monitoring.

Mezoo is a digital healthcare company developing ambulatory Remote Patient Monitoring (aRPM)
solutions to eliminate monitoring blind spots in clinical settings.

By continuously collecting and transmitting patients’ biometric data, Mezoo enables earlier detection of
condition changes and addresses structural challenges such as monitoring gaps, clinical workload, and
limited real-time response outside hospitals. Through advanced wearable technology and data analytics,
Mezoo is building a sustainable patient monitoring environment that connects care inside and outside
the hospital while addressing unmet medical needs.

Vision

Reliable data, human-centered technology, and innovation that leads global standards.

Our research institute is built on the core values of reliable data, human-centered technology, and innovation that defines global standards.
Patient safety and quality of life: by providing solutions that accurately monitor patients’ health anytime, anywhere, we support early diagnosis and maximize treatment effectiveness.
Our institute will continue to challenge and innovate to build a future-oriented healthcare ecosystem that both clinicians and patients can rely on.

01
Improving patient safety and quality of life

We provide solutions that enable accurate monitoring of patient health anytime and anywhere, contributing to early diagnosis and maximized therapeutic outcomes.

02
Convergence of advanced technologies

We build differentiated healthcare platforms that combine multi-biosignal data such as ECG, oxygen saturation, and body temperature with on-device machine learning and AI analytics.

03
Global expansion

We aim to grow into a global digital healthcare leader by developing internationally recognized research outcomes and standardized medical devices beyond the domestic market.

Key research areas and achievements

Milestones that prove meaningful change through technology.
Date Details
2025-02 HiCardi+ Brazilian Medical Device Registration (ANVISA)
2025-01 Implementation of the Market-Driven K-Sensor Technology Development Program by the Ministry of Trade, Industry and Energy
2024-12 Application for a Device and Method for Behavior Analysis Using Accelerometer Data (KR 2024-0197612)
2024-10 HiCardi+ Australian Medical Device Registration (ARTG)
2024-09 HiCardi+ H100 FDA Clearance (510(k))
2024-08 Technical Support Commitment for the Inpatient Monitoring System Implementation Project Using HiCardi+ (PNT, Mezoo)
2024-07 Registration of ECG Lead Guidance System and Method JP 7512554
2024-06 Memorandum of Understanding Signed for Academic Research Projects and Joint Product Development (AITRICS, Mezoo)
2024-04 HiCardi+ H100 Medical Device Registration in Japan (Pharmaceuticals and Medical Devices Agency, PMDA)
2024-03 HiCardi+ Medical Device Registration in Saudi Arabia (Saudi Food and Drug Authority, SFDA)
View More
적용 법률 및 규정
의료기기

하이카디® 시스템은 인허가에 따라 신생아, 소아, 청소년, 18세 이상 환자의 ECG 데이터를 측정하여 부정맥을 진단하는 의료기기로서 의료전문가가 사용하도록 설계되었습니다. 한국 KFDA로부터 의료기기 2등급 인증을 받았습니다. 유럽의료기기 지침(2007/47/EC에 따라 개정된 MDD 93/42/EEC)에 따라 준수된 Class IIb (CE2265). 의료기기 제품으로 CE 승인되었습니다. 미국 FDA는 Class II 510K로 승인 완료 예정입니다.

경고

본 자료는 의료 전문가에게만 배포되며 관련 사진과 함께 제공되는 자료와 관련하여 그 어떤 법적인 책임을 갖지 않습니다. 사용 전 사용 지침서를 주의 깊게 읽으십시오.